Brian Piper
2020
In 2020, Brian Piper earned a total compensation of $2M as Former Chief Financial Officer at Prelude Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $160,988 |
|---|---|
| Option Awards | $1,471,410 |
| Salary | $328,942 |
| Total | $1,961,340 |
Piper received $1.5M in option awards, accounting for 75% of the total pay in 2020.
Piper also received $161K in non-equity incentive plan and $328.9K in salary.
Rankings
In 2020, Brian Piper's compensation ranked 5,606th out of 13,090 executives tracked by ExecPay. In other words, Piper earned more than 57.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,606 out of 13,090 | 57th |
Division Manufacturing | 2,314 out of 5,624 | 59th |
Major group Chemicals And Allied Products | 924 out of 2,257 | 59th |
Industry group Drugs | 799 out of 1,957 | 59th |
Industry Pharmaceutical Preparations | 594 out of 1,462 | 59th |
Source: SEC filing on April 29, 2022.
Piper's colleagues
We found three more compensation records of executives who worked with Brian Piper at Prelude Therapeutics in 2020.